Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 254

1.

Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved?

Reynolds C, Davidson JA, Lindor NM, Glazebrook KN, Jakub JW, Degnim AC, Sandhu NP, Walsh MF, Hartmann LC, Boughey JC.

Ann Surg Oncol. 2011 Oct;18(11):3102-9. doi: 10.1245/s10434-011-1908-8. Epub 2011 Sep 27.

PMID:
21947588
2.

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.

Adem C, Reynolds C, Soderberg CL, Slezak JM, McDonnell SK, Sebo TJ, Schaid DJ, Myers JL, Sellers TA, Hartmann LC, Jenkins RB.

Cancer. 2003 Jan 1;97(1):1-11.

3.
4.

Nipple-sparing mastectomy for breast cancer and risk-reducing surgery: the Memorial Sloan-Kettering Cancer Center experience.

de Alcantara Filho P, Capko D, Barry JM, Morrow M, Pusic A, Sacchini VS.

Ann Surg Oncol. 2011 Oct;18(11):3117-22. doi: 10.1245/s10434-011-1974-y. Epub 2011 Aug 17.

PMID:
21847697
5.

Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.

Petit JY, Veronesi U, Orecchia R, Luini A, Rey P, Intra M, Didier F, Martella S, Rietjens M, Garusi C, DeLorenzi F, Gatti G, Leon ME, Casadio C.

Breast Cancer Res Treat. 2006 Mar;96(1):47-51. Epub 2005 Oct 27.

PMID:
16261402
6.

Prevalence of terminal duct lobular units and frequency of neoplastic involvement of the nipple in mastectomy.

Kryvenko ON, Yoon JY, Chitale DA, Lee MW.

Arch Pathol Lab Med. 2013 Jul;137(7):955-60. doi: 10.5858/arpa.2012-0137-OA.

PMID:
23808467
7.

Occult nipple involvement in breast cancer: clinicopathologic findings in 316 consecutive mastectomy specimens.

Brachtel EF, Rusby JE, Michaelson JS, Chen LL, Muzikansky A, Smith BL, Koerner FC.

J Clin Oncol. 2009 Oct 20;27(30):4948-54. doi: 10.1200/JCO.2008.20.8785. Epub 2009 Aug 31.

PMID:
19720921
8.

Improved sub-areolar breast tissue removal in nipple-sparing mastectomy using hydrodissection.

Folli S, Curcio A, Buggi F, Mingozzi M, Lelli D, Barbieri C, Asioli S, Nava MB, Falcini F.

Breast. 2012 Apr;21(2):190-3. doi: 10.1016/j.breast.2011.09.010. Epub 2011 Oct 2.

PMID:
21967772
9.

Prophylactic nipple-sparing mastectomy leaves more terminal duct lobular units in situ as compared with skin-sparing mastectomy.

van Verschuer VM, van Deurzen CH, Westenend PJ, Rothbarth J, Verhoef C, Luiten EJ, Menke-Pluijmers MB, Koppert LB.

Am J Surg Pathol. 2014 May;38(5):706-12. doi: 10.1097/PAS.0000000000000180.

PMID:
24698963
10.

Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature.

Garcia-Etienne CA, Cody Iii HS 3rd, Disa JJ, Cordeiro P, Sacchini V.

Breast J. 2009 Jul-Aug;15(4):440-9. doi: 10.1111/j.1524-4741.2009.00758.x. Epub 2009 May 22.

PMID:
19496781
11.

Do clinicopathological features of the cancer patient relate with nipple areolar complex necrosis in nipple-sparing mastectomy?

Lohsiriwat V, Rotmensz N, Botteri E, Intra M, Veronesi P, Martella S, Garusi C, De Lorenzi F, Manconi A, Lomeo G, Rietjens M, Schorr M, Kneubil MC, Petit JY.

Ann Surg Oncol. 2013 Mar;20(3):990-6. doi: 10.1245/s10434-012-2677-8. Epub 2012 Oct 16.

PMID:
23070785
12.

Predicting nipple-areolar involvement using preoperative breast MRI and primary tumor characteristics.

Steen ST, Chung AP, Han SH, Vinstein AL, Yoon JL, Giuliano AE.

Ann Surg Oncol. 2013 Feb;20(2):633-9. doi: 10.1245/s10434-012-2641-7. Epub 2012 Sep 11.

PMID:
22965571
13.

Nipple involvement in breast cancer: retrospective analysis of 2323 consecutive mastectomy specimens.

Weidong Li, Shuling Wang, Xiaojing Guo, Ronggang Lang, Yu Fan, Feng Gu, Xinmin Zhang, Zhengmao Zhu, Yun Niu, Li Fu.

Int J Surg Pathol. 2011 Jun;19(3):328-34. doi: 10.1177/1066896911399279. Epub 2011 Mar 31.

PMID:
21454374
14.

Nipple-sparing mastectomy in 99 patients with a mean follow-up of 5 years.

Jensen JA, Orringer JS, Giuliano AE.

Ann Surg Oncol. 2011 Jun;18(6):1665-70. doi: 10.1245/s10434-010-1475-4. Epub 2010 Dec 21.

PMID:
21174155
15.

Management of positive sub-areolar/nipple duct margins in nipple-sparing mastectomies.

Camp MS, Coopey SB, Tang R, Colwell A, Specht M, Greenup RA, Gadd MA, Brachtel E, Austen WG Jr, Smith BL.

Breast J. 2014 Jul-Aug;20(4):402-7. doi: 10.1111/tbj.12279. Epub 2014 Jun 2.

PMID:
24890641
16.

Early results of an endoscopic nipple-sparing mastectomy for breast cancer.

Sakamoto N, Fukuma E, Higa K, Ozaki S, Sakamoto M, Abe S, Kurihara T, Tozaki M.

Ann Surg Oncol. 2009 Dec;16(12):3406-13. doi: 10.1245/s10434-009-0661-8.

PMID:
19662457
17.

Total skin-sparing mastectomy in BRCA mutation carriers.

Peled AW, Irwin CS, Hwang ES, Ewing CA, Alvarado M, Esserman LJ.

Ann Surg Oncol. 2014 Jan;21(1):37-41. doi: 10.1245/s10434-013-3230-0. Epub 2013 Aug 28.

PMID:
23982256
18.

Surgical delay of the nipple-areolar complex: a powerful technique to maximize nipple viability following nipple-sparing mastectomy.

Jensen JA, Lin JH, Kapoor N, Giuliano AE.

Ann Surg Oncol. 2012 Oct;19(10):3171-6. doi: 10.1245/s10434-012-2528-7. Epub 2012 Jul 25.

PMID:
22829005
19.

Preoperative risk assessment among women undergoing bilateral prophylactic mastectomy for cancer risk reduction.

Rueth NM, McMahon M, Arrington AK, Swenson K, Leach J, Tuttle TM.

Ann Surg Oncol. 2011 Sep;18(9):2515-20. doi: 10.1245/s10434-011-1642-2. Epub 2011 Mar 18.

PMID:
21424371
20.

Histological features of extratumoral breast lesions as a predictive factor of familial breast cancer.

Mangia A, Tommasi S, Bruno M, Malfettone A, D'Amico C, Zito FA, Paradiso A, Simone G.

Oncol Rep. 2010 Jun;23(6):1641-5.

PMID:
20428820

Supplemental Content

Support Center